Interestingly, we found that both Cul4A and DDB1 expression levels were increased in A2780CP compared with that in A2780 (Fig. 1d, e), suggesting CRL4 may play a key role in triggering cisplatin resistance of ovarian cancer. Here, IL17RB is linked to ovarian cancer.